Skip to content

Public FDA record

Z-0560-2013: Advantage Workstation Volume Share 2 (versionAW4.4_04) with Volume Viewer 3 and 3.1 (version7.0 to versio

Recall record Z-0560-2013 for GE Healthcare, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0560-2013
Company in FDA record
GE Healthcare, LLC
FDA classification date
Dec 19, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

GE Healthcare has became aware of two issues with the Advantage Workstation. 1) A possible mismatch between the label of the tracked vessel and the underlying image associated with the cardio- vascular applications of the Advantage workstation that may impact patient safety. 2) A refresh problem of the stenosis / aneurysm measurement tools associated with the cardio-vascular applications of

Source facts

Action
GE Healthcare sent two Urgent Medical Device Correction letters dated May 23, 2012, to all affected customers. Each letter addressed a separate issue. The letters described the Safety Issue, Safety Instructions, Affected Product Details, Product Correction, and Contact Information. Customers were instructed to use the following precautions until corrected software was installed: 1. Please avoid the use of leading or trailing spaces in Vessel Names 2. Be sure to press "Show Tracking" after depositing new bifurcation points 3. When eating a multi-point vessel tracking, remove and replace the entire branch, not only the final end-point. 4. When analyzing multi-phase cardiac images, do not delete vessel branches from a phase other than the one in which it was created. Customers were instructed that the new application version that addresses this issue will soon be installed on all systems. Customers with questions or concerns were instructed to call the following: United States 1-800-437-1171. Japan 0120-055-919 For other countries they were instructed to contact their GE Healthcare Service Representative. For questions regarding this recalla call 262-513-4122
Initiated
2012-05-29
Root cause
Software design
Terminated
2013-01-17
Distribution
Worldwide Distribution - USA including AL, CA, CO, FL, GA, IL, IN, IA, MD, MA, MI, MN, MS, MO, MT, NE, NH, NJ, NM, NY, NC, OH, OK, OR, PA, SC, TN, TX , UT, VA, WI and Internationally to the following countries: VENEZUELA, UNITED KINGDOM, UNITED ARAB EMIRATES, TURKEY, TUNISIA, THAILAND, TAIWAN, SWITZERLAND, SPAIN, SOUTH AFRICA, SINGAPORE, SERBIA, SAUDI ARABIA, RUSSIA, ROMANIA, REUNION, PORTUGAL, POLAND, PHILIPPINES, PERU, PANAMA, NORWAY, NIGERIA, NEW CALEDONIA, NEPAL, MEXICO, MALAYSIA, KOREA, JAPAN, ITALY, IRELAND, INDONESIA, INDIA, HONG KONG, GREECE, GERMANY, FRANCE, FINLAND, ESTONIA, EGYPT, ECUADOR, DENMARK, CZECH REPUBLIC, CHINA, CHILE, CANADA, BULGARIA, BRAZIL, BELGIUM, BELARUS, AUSTRIA, AUSTRALIA, ARGENTINA ALGERIA.
Recall number
Z-0560-2013
Recall status
Terminated
CDRH record ID
108512
FDA classified
2012-12-19
Recall event number
61593

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗